20397 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Sub-classes:METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA
#2METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY
#3METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA
#4IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
#5Immunomodulating treatments of body cavities
#6METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A CYP2D6 INHIBITOR
#7SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG
#8TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT
#9METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA
#10METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY
#11STABLE LURBINECTEDIN COMPOSITION
#12METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA
#13Lurbinectedin Composition and Methods Making the Same
#14Bag System Containing a Nutrient Composition Comprising Whole Food Sole Source Meal
#15METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS
#16Polymer excipients for drug delivery applications
#17USES OF COMPOUNDS HAVING ANTI-HSV-1 ACTIVITY
#18METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#19Polymer excipients for drug delivery applications
#20PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE
#21Methods of use of tetrahydroberberine (THB)
#22SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG
#23EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
#24Tumor-selective combination therapy
#25NOVEL METHODS OF USE OF TETRAHYDROBERBERINE (THB)
#26Substituted pyrazino[2,2-a]isoquinoline derivatives
#27Substituted polycyclic carbamoyl pyridone derivative prodrug
#28Substituted pyrazolo[1,5-A]pyridines and their use
#29METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE
#30Compositions including beta-glucans and method of use
#31Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67
#32Anti-CDH6 antibody drug conjugates
#33Tumor-selective combination therapy
#34Methods for treating polycystic kidney disease
#35Combination of kinase inhibitors and uses thereof
#36Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)
#37Compositions including β-glucans and methods of use
#38Screening methods for identifying specific inhibitors
#39Heterocyclic aminoberbamine derivatives, the preparation process and use thereof
#40NOVEL METHODS OF USE OF TETRAHYDROBERBERINE (THB)
#41INTERFERON-INDUCING COMPOUNDS AND USES THEREOF
#42Topoisomerase inhibitors
#43Methods for improving kidney function
#44METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF
#45HEMATOPOIETIC PROTECTION AGAINST CHEMOTHERAPEUTIC COMPOUNDS USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS
#46Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death
#47Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
#48Stabilization of hypoxia inducible factor (HIF) alpha
#49NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#50METHODS FOR INCREASING WHITE BLOOD CELLS
#51SUBSTITUTED TETRACYCLIC 1H-INDENO [1,2-B]PYRIDINE-2(5H)-ONE ANALOGS THEREOF AND USES THEREOF
#52USE OF 9-OXOACRIDINE-10-ACETIC ACID, SALTS AND ESTERS THEREOF IN COMBINATION THERAPY OF OVARIAN CANCER
#53Macrocyclic inhibitors of hepatitis C virus replication
#54Neurotrophin antagonist compositions
#55INHIBITION OF NF-KB
#56Neurotrophin antagonist compositions
#57Methods and Compositions for Treatment of Scleritis and Related Disorders
#58Stabilization of hypoxia inducible factor (HIF) alpha
#59Stabilization of hypoxia inducible factor (HIF) alpha
#60Stabilization of hypoxia inducible factor (HIF) alpha
#61Methods of increasing endogenous erythropoietin (EPO)
#62Methods of increasing endogenous erythropoietin (EPO)
#63Methods of increasing endogenous erythropoietin (EPO)
#64Neurotrophin antagonist compositions
#65Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient